Navigation Links
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
Date:9/18/2012

CAMBRIDGE, Mass., Sept. 18, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) announced today the appointment of two new independent Directors to the Company's Board of Directors. Scott A. Canute and Gino Santini provide Inspiration access to unparalleled expertise in biopharmaceuticals manufacturing and business development as the company moves toward commercialization of its portfolio of products currently in late-stage development for hemophilia. The new independent Directors were appointed by specialty pharmaceutical company Ipsen, who holds rights to commercialize Inspiration's two late-stage hemophilia product candidates in Europe and certain other territories. Ipsen gained the right to designate two new members to Inspiration's board under the terms of agreements announced by the companies on August 21, 2012.

"We are pleased to have our Board enhanced by these talented executives," said John Taylor, Co-Founder and Chairman of the Board of Inspiration. "They deeply understand Inspiration's mission to broaden treatment choices, expand global access to care and advance innovative therapies for the hemophilia community. Each brings a unique set of experiences that will be instrumental to Inspiration as we continue to develop as an independent company and work to create new products to help people with hemophilia."

Scott A. Canute has over 30 years of experience in the biopharmaceutical industry. He has most recently served as the President of Global Manufacturing and Corporate Operations and Executive Vice President of Genzyme Corporation from March 2010 to July 2011, leading a major turnaround effort for the manufacturing division of the global biotechnology company. Prior to that, Mr. Canute spent 25 years at Eli Lilly and Company in a variety of positions culminating in his becoming President of Manufacturing in 2004. Mr. Canute is currently a board member of Oncobiologics, Inc. and has been a past board member of th
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014 The Society of Corporate Compliance ... more than 4,500 compliance and ethics professionals from ... chronicles corporate fines and settlements.  The SCALENDAR is ... a ready reference to demonstrate to employees the ... SCALENDAR to help compliance and ethics officers looking ...
(Date:9/15/2014)... Sept. 15, 2014  Over 200 patients, families, ... Saturday to learn, interact and participate in the ... first Lupus Trials Fair launched by the ... S.L.E. Lupus Foundation .  Attendees interacted directly with ... sharing experiences, ideas and needs and learning about ...
(Date:9/15/2014)... , Sept. 15, 2014 Research ... "Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014" ... (CAS 103-90-2) Market Research Report 2014 presents comprehensive data ... Europe , Asia , ... The report includes paracetamol (acetaminophen) description, covers its application ...
Breaking Medicine Technology:More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 2Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 3
... PHILADELPHIA, Dec. 23, 2011 Arctic Ease is proud to ... has joined Team Arctic Ease®.  Davis will serve as a ... well as introduce Arctic Ease® to millions of sports fans ... a form of cold therapy that are odorless, menthol free ...
... 2011  Rochester Medical Corporation (Nasdaq: ROCM ) announced ... of Directors following the conclusion of the Company,s 2012 Annual ... which is the end of his current term. ... Schnobrich has served on our Board since 1995.  His cheerful ...
Cached Medicine Technology:Vernon Davis Joins Team Arctic Ease® as Spokesperson for Arctic Ease® Cryotherapy Wraps and Pads 2Vernon Davis Joins Team Arctic Ease® as Spokesperson for Arctic Ease® Cryotherapy Wraps and Pads 3Rochester Medical Director Schnobrich to Retire 2
(Date:9/15/2014)... one out of every 40 individuals in the United States ... atrophy (SMA), a neurodegenerative disease that causes muscles to weaken ... made a recent breakthrough with the development of a new ... the disease. In April, a patent was filed for the ... is using to fight SMA is to ,repress the repressor," ...
(Date:9/15/2014)... September 15, 2014 In order to ... medicine often act conjointly to quantify, define and model ... become an integral part of medical care. , The ... the studies conducted by the non-profit Institute of BioAcoustic ... demonstrated that math can be much more than a ...
(Date:9/15/2014)... Dennis Thompson ... News) -- The severe respiratory virus believed to have ... states has now spread to the Northeast, health officials ... confirmed on Friday more than a dozen cases of ... for children with asthma. And on Saturday, the ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 As ... end of its first full year, there are ... maturing; especially in the evolution of its marketing ... approach being taken by Denver's Kindman, one of ... and distributors. , Kindman has pioneered the first-ever ...
(Date:9/15/2014)... September 15, 2014 As Risperdal lawsuits ... Bernstein Liebhard LLP notes that a new study has ... curbing aggression in children with ADHD when it is ... in behavioral management techniques. According to a report from ... and aggression problems, half of whom took Concerta, a ...
Breaking Medicine News(10 mins):Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 2Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 4
... TUESDAY, Aug. 30 (HealthDay News) -- Genes affect hereditary coronary ... a new study. While it,s long been known that ... this is due to genes or unhealthy lifestyle in the ... that question, the investigators examined the health records of 80,214 ...
... not how old but how frail patients are that can predict ... young patients in poor health may have worse outcomes than older ... University of Michigan Comprehensive Cancer Center finds that patients with decreased ... to distant parts of the body. These findings may ...
... of Medicine researchers have found that climate change may lead ... room (ER) visits in the next decade. The data, ... Preventive Medicine, found that changing levels of ozone could lead ... by children, ages 0-17. The research team, ...
... August 30, 2011Despite recent concerns that changes in atmospheric ... insulin delivered via pump devices, the current evidence is ... more data are available, according to an insightful editorial ... journal published by Mary Ann Liebert, Inc. The editorial ...
... An Indiana University study that compared strategies used by extroverted ... happy people who are less outgoing relied less on partying ... family and friends or cognitive strategies, such as positive thinking. ... to be happy. That,s the thing students feel they need ...
... TUESDAY, Aug. 30 (HealthDay News) -- Swedish scientists have identified ... a harbinger of an increased risk of death among elderly ... the inflammatory processes that are central to killers such as ... study, published online Aug. 30 in the Journal of ...
Cached Medicine News:Health News:Patients' underlying health linked to worse outcomes for melanoma, U-M study finds 2Health News: Happiness: All in who you know, goals 2Health News:Blood Protein Might Signal Death Risk in Elderly 2
... LactoSorb copolymer is an absorbable co-polymer ... acid and 18% glycolic acid. Unlike ... as 100% poly-L-lactic acid (PLLA) or ... is substantially amorphous (without crystallinity), meaning ...
... Tissue Anchor 2 mm is a resorbable repair ... using sutures. The resorbable repair device is implanted ... is used to reattach damaged soft tissue. The ... derived from glycolide and lactide colored with D&C ...
... of anchor is generally used when ... This 2.9mm anchor is packaged sterile ... or 2-0) and needles. Although pre-drilling ... the Mini Harpoon®, 1.6mm & 1.8mm ...
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Medicine Products: